291 related articles for article (PubMed ID: 23100049)
21. Use of a benzimidazole derivative BF-188 in fluorescence multispectral imaging for selective visualization of tau protein fibrils in the Alzheimer's disease brain.
Harada R; Okamura N; Furumoto S; Yoshikawa T; Arai H; Yanai K; Kudo Y
Mol Imaging Biol; 2014 Feb; 16(1):19-27. PubMed ID: 23868612
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography.
Ishiki A; Okamura N; Furukawa K; Furumoto S; Harada R; Tomita N; Hiraoka K; Watanuki S; Ishikawa Y; Tago T; Funaki Y; Iwata R; Tashiro M; Yanai K; Kudo Y; Arai H
PLoS One; 2015; 10(10):e0140311. PubMed ID: 26461913
[TBL] [Abstract][Full Text] [Related]
23. Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue.
Choi SR; Schneider JA; Bennett DA; Beach TG; Bedell BJ; Zehntner SP; Krautkramer MJ; Kung HF; Skovronsky DM; Hefti F; Clark CM
Alzheimer Dis Assoc Disord; 2012; 26(1):8-16. PubMed ID: 22354138
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of 2-pyrrolopyridinylquinoline derivatives as selective tau PET tracers for the diagnosis of Alzheimer's disease.
Lerdsirisuk P; Harada R; Hayakawa Y; Shimizu Y; Ishikawa Y; Iwata R; Kudo Y; Okamura N; Furumoto S
Nucl Med Biol; 2021 Feb; 93():11-18. PubMed ID: 33221641
[TBL] [Abstract][Full Text] [Related]
25. Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue.
Ni R; Gillberg PG; Bergfors A; Marutle A; Nordberg A
Brain; 2013 Jul; 136(Pt 7):2217-27. PubMed ID: 23757761
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and preliminary evaluation of 2-arylhydroxyquinoline derivatives for tau imaging.
Tago T; Furumoto S; Okamura N; Harada R; Ishikawa Y; Arai H; Yanai K; Iwata R; Kudo Y
J Labelled Comp Radiopharm; 2014 Jan; 57(1):18-24. PubMed ID: 24448742
[TBL] [Abstract][Full Text] [Related]
27. 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients.
Kudo Y; Okamura N; Furumoto S; Tashiro M; Furukawa K; Maruyama M; Itoh M; Iwata R; Yanai K; Arai H
J Nucl Med; 2007 Apr; 48(4):553-61. PubMed ID: 17401091
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and Evaluation of Fluorine-18 Labeled 2-Phenylquinoxaline Derivatives as Potential Tau Imaging Agents.
Zhou K; Yang F; Li Y; Chen Y; Zhang X; Zhang J; Wang J; Dai J; Cai L; Cui M
Mol Pharm; 2021 Mar; 18(3):1176-1195. PubMed ID: 33475377
[TBL] [Abstract][Full Text] [Related]
29. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
[TBL] [Abstract][Full Text] [Related]
30. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease.
Agdeppa ED; Kepe V; Liu J; Flores-Torres S; Satyamurthy N; Petric A; Cole GM; Small GW; Huang SC; Barrio JR
J Neurosci; 2001 Dec; 21(24):RC189. PubMed ID: 11734604
[TBL] [Abstract][Full Text] [Related]
31. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
Watanabe H
Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
[TBL] [Abstract][Full Text] [Related]
32. The Sensitivity of Tau Tracers for the Discrimination of Alzheimer's Disease Patients and Healthy Controls by PET.
Mohammadi Z; Alizadeh H; Marton J; Cumming P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830659
[TBL] [Abstract][Full Text] [Related]
33. Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain.
Okamura N; Suemoto T; Shimadzu H; Suzuki M; Shiomitsu T; Akatsu H; Yamamoto T; Staufenbiel M; Yanai K; Arai H; Sasaki H; Kudo Y; Sawada T
J Neurosci; 2004 Mar; 24(10):2535-41. PubMed ID: 15014129
[TBL] [Abstract][Full Text] [Related]
34. Preclinical Evaluation of
Honer M; Gobbi L; Knust H; Kuwabara H; Muri D; Koerner M; Valentine H; Dannals RF; Wong DF; Borroni E
J Nucl Med; 2018 Apr; 59(4):675-681. PubMed ID: 28970331
[TBL] [Abstract][Full Text] [Related]
35. Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue.
Lemoine L; Ledreux A; Mufson EJ; Perez SE; Simic G; Doran E; Lott I; Carroll S; Bharani K; Thomas S; Gilmore A; Hamlett ED; Nordberg A; Granholm AC
Mol Neurodegener; 2020 Nov; 15(1):68. PubMed ID: 33222700
[TBL] [Abstract][Full Text] [Related]
36. Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies.
Thompson PW; Ye L; Morgenstern JL; Sue L; Beach TG; Judd DJ; Shipley NJ; Libri V; Lockhart A
J Neurochem; 2009 Apr; 109(2):623-30. PubMed ID: 19226369
[TBL] [Abstract][Full Text] [Related]
37. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits.
Johnson AE; Jeppsson F; Sandell J; Wensbo D; Neelissen JA; Juréus A; Ström P; Norman H; Farde L; Svensson SP
J Neurochem; 2009 Mar; 108(5):1177-86. PubMed ID: 19141073
[TBL] [Abstract][Full Text] [Related]
38. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
[TBL] [Abstract][Full Text] [Related]
39. 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease.
Harada R; Okamura N; Furumoto S; Furukawa K; Ishiki A; Tomita N; Tago T; Hiraoka K; Watanuki S; Shidahara M; Miyake M; Ishikawa Y; Matsuda R; Inami A; Yoshikawa T; Funaki Y; Iwata R; Tashiro M; Yanai K; Arai H; Kudo Y
J Nucl Med; 2016 Feb; 57(2):208-14. PubMed ID: 26541774
[TBL] [Abstract][Full Text] [Related]
40. Tau PET imaging in Alzheimer's disease.
Okamura N; Harada R; Furumoto S; Arai H; Yanai K; Kudo Y
Curr Neurol Neurosci Rep; 2014 Nov; 14(11):500. PubMed ID: 25239654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
